Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration

Current Eye Research

Volumn 30, Issue 7, 2005, Pages 563-567

  Price, Marianne O ^a   Quillin, Clorissa ^a   Price Jr , Francis W ^b  

^a Lautert)   (United States)

^b PRICE VISION GROUP   (United States)

Author keywords

Aqueous humor concentration; Cataract surgery; Corneal endothelial cell density; Corneal toxicity; Gatifloxacin ophthalmic solution

Indexed keywords

GATIFLOXACIN;

ADULT; ANTIBACTERIAL ACTIVITY; AQUEOUS HUMOR; ARTICLE; CATARACT EXTRACTION; CELL DENSITY; CLINICAL ARTICLE; CORNEA ENDOTHELIUM; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; ENDOTHELIUM CELL; FEMALE; GRAM NEGATIVE INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SURGICAL PATIENT;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CATARACT EXTRACTION; CELL COUNT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOTHELIUM, CORNEAL; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS;

EID: 23444456449     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680590968556     Document Type: Article

References (10)

1. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol. 2003;121:345-350.
2. Lopez JG, Hagenah M, Insler MS. Growth factors and corneal endothelial healing. In: Beuerman RW, Crosson CE, Kaufman HE. Healing Processes in the Cornea. The Woodlands: The Portfolio Publishing Company; 1989;139-150.
3. Walkow T, Anders N, Klebe S. Endothelial cell loss after phacoemulsification: relation to preoperative and intraoperative parameters. J Cataract Refract Surg. 2000;26:727-732.
4. Ravalico G, Botteri E, Baccara F. Long-term endothelial changes after implantation of anterior chamber intraocular lenses in cataract surgery. J Cataract Refract Surg. 2003;29:1918-1923.
5. Liang H, Kays MB, Sowinski KM. Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;772:53-63.
6. McDermott ML, Hazlett LD, Barrett R. The effect of ofloxacin on the human corneal endothelium. Cornea. 1997;16:209-214.
7. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109:13-24.
8. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF and the Endophthalmitis Vitrectomy Study Group. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthal. 1996;122:1-17.
9. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthal. 2002;133:463-466.
10. Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS, Ritterband DC, Gordon J. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthal. 2003;136:500-505.